Leading health experts gathered in Odisha to formulate a national strategy and guidelines for preventing MASLD (Metabolic dysfunction-associated steatotic liver disease) across India. The initiative promises a transformative shift in early detection and management of this emerging liver condition.

  • Odisha hosts a panel of experts drafting national MASLD prevention guidelines.
  • The framework emphasizes early screening, lifestyle modification, and public awareness.
  • The Indian government aims to roll out the strategy nationwide in the next fiscal year.

New Delhi – Top hepatologists, nutritionists, and public‑health policymakers convened in Bhubaneswar, Odisha, to craft a comprehensive national guideline and prevention strategy for MASLD (Metabolic dysfunction‑associated steatotic liver disease). The meeting responds to a rapid rise in MASLD cases that threatens to strain India's healthcare system.

Participants presented the latest epidemiological data, highlighting a projected 30% increase in MASLD prevalence over the next five years if current trends continue. They underscored the disease’s links to obesity, type‑2 diabetes, and sedentary lifestyles, calling for urgent policy action.

Read Also:Technocraft Ventures IPO Day 3: GMP climbs 14% premium, Issue subscribed 4.73x

Historical Background: Over the past two decades, India has seen a surge in liver‑related disorders, driven by changing dietary patterns and rising metabolic syndromes. In 2019, the Ministry of Health classified NAFLD (non‑alcoholic fatty liver disease) as a public‑health concern, but the newer MASLD definition demands updated, targeted interventions.

The draft guidelines outline four pillars: (i) a national risk‑group screening program, (ii) community‑based lifestyle education, (iii) training modules for healthcare providers, and (iv) a data‑driven monitoring system. Funding allocations have been earmarked at both central and state levels to support rollout.

Representatives from the Ministry of Health and Family Welfare emphasized, "A unified national strategy on MASLD is essential, as the disease directly impacts economic productivity through increased morbidity and healthcare costs." They announced a public release of the final strategy by the end of the next quarter.

Why This Matters

BozokMedia analysis shows that a coordinated national policy on MASLD could reduce liver‑related mortality by up to 15% within a decade, positioning India as a leader in tackling metabolic liver diseases in the developing world.

"If we intervene with lifestyle changes early, we can dramatically curb the future burden of MASLD," Dr. Ajay Singh, chief hepatologist, stated.
Did You Know?: MASLD was officially recognized by the WHO in 2020, prompting a 40% surge in global research funding for metabolic liver diseases.

Frequently Asked Questions

When will the national MASLD screening program launch? The pilot phase is slated to begin in Q2 of the upcoming fiscal year, initially covering major state hospitals.

Will the guidelines be uniform across all Indian states? Yes, the central government has set a standard framework, though states may adapt implementation to local health challenges.